{
    "organizations": [],
    "uuid": "ff9e92ccda9fb4a720a10d0d22c3308ebbb118d0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-histogenics-reports-q1-loss-per-sh/brief-histogenics-reports-q1-loss-per-share-of-0-52-idUSASC0A1BL",
    "ord_in_thread": 0,
    "title": "BRIEF-Histogenics Reports Q1 Loss Per Share Of $0.52",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Histogenics Corp:\n* ORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS\n* Q1 LOSS PER SHARE $0.52 * Q1 EARNINGS PER SHARE VIEW $-0.22 â€” THOMSON REUTERS I/B/E/S\n* HISTOGENICS - TOP-LINE SUPERIORITY DATA FROM NEOCART PHASE 3 CLINICAL TRIAL, POTENTIAL BLA SUBMISSION ON TRACK FOR Q3 OF 2018\n* AS OF MARCH 31, 2018, CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $15.5 MILLION, VERSUS $8.0 MILLION AT DECEMBER 31, 2017\n* BELIEVES ITS CURRENT CASH POSITION WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO Q4 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T18:34:00.000+03:00",
    "crawled": "2018-05-11T12:50:26.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "histogenics",
        "corp",
        "oration",
        "announces",
        "first",
        "quarter",
        "financial",
        "operating",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "histogenics",
        "superiority",
        "data",
        "neocart",
        "phase",
        "clinical",
        "trial",
        "potential",
        "bla",
        "submission",
        "track",
        "q3",
        "march",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "million",
        "versus",
        "million",
        "december",
        "belief",
        "current",
        "cash",
        "position",
        "sufficient",
        "fund",
        "operation",
        "q4",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}